MARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Cantor Global Healthcare Conference | New York, NY
Wednesday, September 3, 2025
Fireside Chat (1:35 PM ET): Click here to access
Lake Street BIG9 Best Ideas Growth Conference | New York, NY
Thursday, September 11, 2025
1:1 sessions
Investors interested in meeting with senior management at these events may contact their respective Cantor or Lake Street representative.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com


Đề xuất
Curiox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code Deployment
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
Triple Green Farms CBD Gummies Claims Evaluated: The Best CBD Gummy Formula on the Market Under Investigation
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
ViGenCell’s VT-EBV-N Selected for Oral Presentation at ASCO 2026